ROHTO PHARMACEUTICAL CO.,LTD.
ロート製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4527
FY2025 · 2026-03-31
| Gross margin | 56.1% |
| Operating margin | 12.0% |
| Net margin | 10.0% |
| Return on equity | 13.5% |
| Return on assets | 7.1% |
| Revenue growth (YoY) | 11.4% |
| EPS (basic) | ¥151.56 |
| EPS growth (YoY) | 11.4% |
| Current ratio | 2.04x |
| Equity ratio | 52.1% |
| Book value / share | ¥1,334.04 |
| Free cash flow | 36,294 M |